PTK2 and renal cell carcinoma: In a study of human renal cell carcinoma (RCC), the proto-oncogene Golgi phosphoprotein 3 (GOLPH3) was able to activate simultaneously the FAK/Raf/MEK pathway and Wnt/β-catenin promoting RCC cell proliferation and malignancy.